Duarte (1)

Autologous Hematopoietic Stem Cell Transplant Recipient (1)

Loss of Chromosome 17p (1)

Plasma Cell Leukemia (1)

Recurrent Plasma Cell Myeloma (1)

Refractory Plasma Cell Myeloma (1)

Active, not recruiting (1)

phase 1 (1)

City of Hope Medical Center (1)

National Cancer Institute (NCI) (1)

bortezomib (1)

fludarabine phosphate (1)

laboratory biomarker analysis (1)

melphalan (1)

peripheral blood stem cell transplantation (1)

sirolimus (1)

tacrolimus (1)

total marrow irradiation (1)

drug (1)

other (1)

procedure (1)

radiation (1)

Other (1)

Interventional (1)

autologous hematopoietic stem cell transplant recipient

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Active, not recruiting

Mar 17, 2022